Summary
Changes in transmembrane sodium fluxes have been reported in normotensive and in hypertensive subjects after ketanserin administration. In this study, the effects of the serotonergic system on transmembrane sodium transport mechanisms have been investigated in vitro. In erythrocytes drawn from ten healthy subjects, we studied the effects of serotonin (5HT) on the Na/K pump, Na/K cotransport, Na/Li countertransport, and passive permeability of Na. No significant changes were found. A direct, non-receptor-mediated action of ketanserin was then suspected, and the effects of two concentrations of ketanserin (5×10-8 and 5×10-7 M) were evaluated in erythrocytes from 12 normal volunteers. Both concentrations of ketanserin significantly decreased the activity of the Na/K pump and increased the activity of Na/Li countertransport. Na/K cotransport and passive permeability were not affected. Indirect evidence of the action of ketanserin on sodium transmembrane fluxes came from other experiments. In the red blood cells taken from five normal subjects and incubated for 2 hours in a plasma pool, we evaluated the changes in intracellular sodium concentration induced by the presence of 5HT or ketanserin. A significant decrease in intracellular sodium concentration occurred only with ketanserin. This study indicates that ketanserin has a direct influence on transmembrane sodium fluxes. If this action were also present in other cells, it might contribute to the actions of the drug at vascular, nervous, and renal tubular levels.
Similar content being viewed by others
References
Tedde R, Sechi LA, Marigliano A, Campus S. Sodium concentration in erythrocytes in arterial hypertension. J Hypertens 1983;1(2):140–141.
Meyer P, Garay RP, De Mendonca M. Ion transport systems in hypertension. In: Genest J, Kuchel O, Hamet P, Cantin M, eds. Hypertension, New York: McGraw-Hill, 1983;108–116.
Hilton PJ. Cellular sodium transport in essential hypertension. N Engl J Med 1986;314:222–228.
Quintanilla AP, Finn M, Weffer MI, Del Greco F. Effect of treatment with hydrochlorothiazide on the red cell Na, K-adenosine triphosphatase in men with hypertension. J Lab Clin Med 1987;110(5):583–587.
Araoye MA, Khatri IM, Yao LL, Freis ED. Leukocyte intracellular cations in hypertension: Effect of antihypertensive drugs. Am Heart J 1978;96:731–738.
De Cree J, Leempoels J, Demoen B, Verhaegen H. Ketanserin and red blood cell sodium content in hypertension. J Cardiovasc Pharmacol 1985;7(7):S41-S43.
Lijnen P, M'Buyamba-Kabangu JR, Fagard R, Fiocchi R, Staessen J, Amery A. Effects of ketanserin on the in tracellular concentration and on transmembrane fluxes of sodium and potassium in erythrocytes of normal male subjects. J Cardiovasc Pharmacol 1985;7(7):S38-S40.
Sechi LA, Tedde R, Cassisa L, et al. Clinical experiences with ketanserin in the treatment of essential hypertension. In: Paoletti R, Vanhoutte PM, eds. Serotonin, From CellBiology to Pharmacology and Therapeutics. Lancaster: Kluwer Academic Publishers, in press.
Sechi LA, Tedde R, Cassisa L, et al. Effects of ketanserin on transmembrane sodium transport in erythrocytes. J Cardiovasc Pharmacol, in press.
Reimann IW, Okonkwo PO, Klotz U. Pharmacokinetics of ketanserin in man. Eur J Clin Pharmacol 1983;25:73–76.
Pletscher A, Affolter H. The 5-hydroxytryptamine receptors of blood platelets. J Neurol Trans 1983;57:233–242.
D'Amore P, Shepro D. Captation of 5-hydroxytryptamine and effects on endothelial cell metabolism. In: De Clerck F, Vanhoutte PM, eds. 5-Hydroxytryptamine in Peripheral Reactions. New York: Raven Press, 1982;37–47.
Bradley PB, Engel G, Feniuk W, et al. Proposals for the classification and the nomenclature of functional receptors for 5-hydroxytryptamine. Neuropharmacology 1986;25: 563–576.
Zannad F, Voisin P, Pointel JP, Schmitt C, Freitag B, Stoltz JF. Effects of ketanserin on platelet function and red cell filterability in hypertension and peripheral vascular disease. J Cardiovasc Pharmacol 1985;7(7):S32-S34.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sechi, L.A., Tedde, R., Cassisa, L. et al. Evidence for a direct and non-receptor-mediated action of 5HT2 antagonists on transmembrane cation transport systems. Cardiovasc Drug Ther 4, 63–67 (1990). https://doi.org/10.1007/BF00053429
Issue Date:
DOI: https://doi.org/10.1007/BF00053429